These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 33587950)

  • 1. Cellular senescence and hematological malignancies: From pathogenesis to therapeutics.
    Hu D; Yuan S; Zhong J; Liu Z; Wang Y; Liu L; Li J; Wen F; Liu J; Zhang J
    Pharmacol Ther; 2021 Jul; 223():107817. PubMed ID: 33587950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stromal cell senescence in haematological malignancies.
    Plakhova N; Panagopoulos V; Vandyke K; Zannettino ACW; Mrozik KM
    Cancer Metastasis Rev; 2023 Mar; 42(1):277-296. PubMed ID: 36622509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aging- and Senescence-associated Changes of Mesenchymal Stromal Cells in Myelodysplastic Syndromes.
    Mattiucci D; Maurizi G; Leoni P; Poloni A
    Cell Transplant; 2018 May; 27(5):754-764. PubMed ID: 29682980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone Marrow Senescence and the Microenvironment of Hematological Malignancies.
    Hellmich C; Moore JA; Bowles KM; Rushworth SA
    Front Oncol; 2020; 10():230. PubMed ID: 32161723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute myeloid leukemia induces protumoral p16INK4a-driven senescence in the bone marrow microenvironment.
    Abdul-Aziz AM; Sun Y; Hellmich C; Marlein CR; Mistry J; Forde E; Piddock RE; Shafat MS; Morfakis A; Mehta T; Di Palma F; Macaulay I; Ingham CJ; Haestier A; Collins A; Campisi J; Bowles KM; Rushworth SA
    Blood; 2019 Jan; 133(5):446-456. PubMed ID: 30401703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of cellular senescence and SASP in tumour microenvironment.
    Takasugi M; Yoshida Y; Hara E; Ohtani N
    FEBS J; 2023 Mar; 290(5):1348-1361. PubMed ID: 35106956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High mobility group box 1 (HMGB1): a pivotal regulator of hematopoietic malignancies.
    Yuan S; Liu Z; Xu Z; Liu J; Zhang J
    J Hematol Oncol; 2020 Jul; 13(1):91. PubMed ID: 32660524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Cell Senescence for the Treatment of Age-Related Bone Loss.
    Pignolo RJ; Samsonraj RM; Law SF; Wang H; Chandra A
    Curr Osteoporos Rep; 2019 Apr; 17(2):70-85. PubMed ID: 30806947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overcoming the senescence-associated secretory phenotype (SASP): a complex mechanism of resistance in the treatment of cancer.
    Chambers CR; Ritchie S; Pereira BA; Timpson P
    Mol Oncol; 2021 Dec; 15(12):3242-3255. PubMed ID: 34137158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantifying Senescence-Associated Phenotypes in Primary Multipotent Mesenchymal Stromal Cell Cultures.
    Nadeau S; Cheng A; Colmegna I; Rodier F
    Methods Mol Biol; 2019; 2045():93-105. PubMed ID: 31020633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The senescence-associated secretory phenotype (SASP) from mesenchymal stromal cells impairs growth of immortalized prostate cells but has no effect on metastatic prostatic cancer cells.
    Alessio N; Aprile D; Squillaro T; Di Bernardo G; Finicelli M; Melone MA; Peluso G; Galderisi U
    Aging (Albany NY); 2019 Aug; 11(15):5817-5828. PubMed ID: 31412320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular senescence and liver disease: Mechanisms and therapeutic strategies.
    Guo M
    Biomed Pharmacother; 2017 Dec; 96():1527-1537. PubMed ID: 29174037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular Senescence as a Therapeutic Target for Age-Related Diseases: A Review.
    Amaya-Montoya M; Pérez-Londoño A; Guatibonza-García V; Vargas-Villanueva A; Mendivil CO
    Adv Ther; 2020 Apr; 37(4):1407-1424. PubMed ID: 32185730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An early-senescence state in aged mesenchymal stromal cells contributes to hematopoietic stem and progenitor cell clonogenic impairment through the activation of a pro-inflammatory program.
    Gnani D; Crippa S; Della Volpe L; Rossella V; Conti A; Lettera E; Rivis S; Ometti M; Fraschini G; Bernardo ME; Di Micco R
    Aging Cell; 2019 Jun; 18(3):e12933. PubMed ID: 30828977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pro- and anti-tumorigenic functions of the senescence-associated secretory phenotype.
    Lau L; David G
    Expert Opin Ther Targets; 2019 Dec; 23(12):1041-1051. PubMed ID: 30616404
    [No Abstract]   [Full Text] [Related]  

  • 16. A tale of the good and bad: Cell senescence in bone homeostasis and disease.
    Liu X; Wan M
    Int Rev Cell Mol Biol; 2019; 346():97-128. PubMed ID: 31122396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular senescence in the pathogenesis of ovarian dysfunction.
    Harada M
    J Obstet Gynaecol Res; 2024 May; 50(5):800-808. PubMed ID: 38412992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles and mechanisms of cellular senescence in regulation of tissue homeostasis.
    Ohtani N; Hara E
    Cancer Sci; 2013 May; 104(5):525-30. PubMed ID: 23360516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Quantitative Measurement of Reactive Oxygen Species and Senescence-associated Secretory Phenotype in Normal Human Fibroblasts During Oncogene-induced Senescence.
    Kim YY; Um JH; Yun J
    J Vis Exp; 2018 Aug; (138):. PubMed ID: 30148482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation-Induced Osteocyte Senescence Alters Bone Marrow Mesenchymal Stem Cell Differentiation Potential via Paracrine Signaling.
    Xu L; Wang Y; Wang J; Zhai J; Ren L; Zhu G
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.